Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2000, p. 99-104, Vol. 38, No. 1
Newfoundland Public Health Laboratory, St.
John's, Newfoundland,1 Viral Exanthema
Laboratory, Laboratory Centre for Disease Control, Winnipeg,
Manitoba,2 Laboratoire de Sante Publique
du Quebec, Ste-Anne-de-Bellevue, Quebec,3
Central Public Health Laboratory, Ontario Ministry of Health,
Laboratory Services Branch, Toronto, Ontario,4
and McGill Centre for the Study of Host Resistance, Montreal
General Hospital, Montreal, Quebec,5 Canada
Received 4 May 1999/Returned for modification 25 August
1999/Accepted 8 October 1999
As progress is made toward elimination of measles, the laboratory
confirmation of measles becomes increasingly important. However, both
false-positive and false-negative results can occur with the routinely
used indirect measles immunoglobulin M (IgM) serology tests. The
measles IgM capture assay is considered to be more specific, and
therefore, its use is indicated for confirmatory testing, but its
relative performance has not been fully assessed. Four commercial
indirect measles IgM serology test kits (the Behring, Clark, Gull, and
PanBio assays) and a commercial IgM capture assay (the Light
Diagnostics assay) were evaluated for their abilities to detect measles
virus-specific IgM antibody with a total of 308 serum samples from
patients involved in a measles outbreak and with confirmed cases of
measles and 454 samples from subjects without measles. The Centers for
Disease Control and Prevention (CDC) IgM capture assay was also used in
a part of the evaluation. Among the indirect assays, the overall
sensitivities ranged from 82.8% (Clark assay) to 88.6% (Behring
assay) and specificity ranged from 86.6% (PanBio assay) to 99.6%
(Gull assay). These rates were 92.2 and 86.6%, respectively, for the
Light Diagnostics capture assay and 87.0 and 94.8%, respectively, for
the CDC capture assay. While the Light Diagnostics capture assay had
the best detection rate (80%) with the acute-phase samples compared
with those for the rest of the tests (CDC capture assay, 77%; Behring
assay, 70%; Gull assay, 69%; PanBio assay, 58%; and Clark assay,
57%), all tests showed a significantly improved sensitivity in the
range of 92% (Clark and PanBio assays) to 97% (Light Diagnostics and CDC capture assays) with the convalescent-phase samples, as expected. The best seropositivity rates (in the range of 92 to 100%) were observed with samples collected 6 to 14 days after the onset of symptoms. The Gull assay showed the highest positive predictive value
(99.6%), followed by the Behring assay (97.8%) and the CDC capture
assay (96.1%). Overall, the Gull and Behring assays were found to be
as good as or better than the capture assays. In conclusion, laboratory
diagnosis of measles based on IgM serology varies depending on the
timing of specimen collection and the test used, and the case for the
use of the IgM capture assay as the confirmatory test appears to be uncertain.
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Performance of Indirect Immunoglobulin M (IgM)
Serology Tests and IgM Capture Assays for Laboratory Diagnosis of
Measles
,*

and
*
Corresponding author. Mailing address: Public Health
Laboratory, Leonard A. Miller Centre, St. John's, NF, Canada A1B 3T2. Phone: (709) 737-6565. Fax: (709) 737-7070 or (709) 737-6611. E-mail:
nphlab{at}newcomm.net.
Member of the Laboratory Subcommittee, Working Group on Measles
Elimination in Canada.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»